Lymph directing prodrugs
US-2024050573-A1 · Feb 15, 2024 · US
Compositions and methods for preventing cardiac arrhythmia
US8980296B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8980296-B2 |
| Application number | US-70742710-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 17, 2010 |
| Priority date | Feb 18, 2009 |
| Publication date | Mar 17, 2015 |
| Grant date | Mar 17, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed herein are compositions and methods for treating or preventing cardiac arrhythmia in a subject.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating post-operative atrial fibrillation in a subject, comprising: providing an extracellular matrix (ECM) composition comprising acellular ECM and a statin, said statin being linked to said ECM, wherein, when said ECM composition is administered to damaged cardiovascular tissue, said ECM composition modulates inflammation of said damaged cardiovascular tissue and induces myofibroblast proliferation and angiogenesis; and delivering a therape…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8980296B2 cover?
- Disclosed herein are compositions and methods for treating or preventing cardiac arrhythmia in a subject.
- Who is the assignee on this patent?
- Matheny Robert G, Lewis Beecher C, Cormatrix Cardiovascular Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/138. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).